Perella WEinberg Partners LP

Pernix Therapeutics Holdings Inc (NASDAQ: PTX) shares have dipped 74.85 percent over the past one year, almost down to their 52-week low on February 5, at $1.99. Brean Capital’s Difei Yang has maintained a Buy rating on the company, while lowering the price target from $14 to $8. On...